drug rebates

The Trump Administration has proposed a major change in the way drugs are priced for Medicare beneficiaries. The new rules would upend the current complex and opaque pricing system for pharmaceuticals, lower prices for users of some costly drugs (though not others), and raise Medicare Part D premiums for everyone. Whether you win or lose under the new system would [...]